Cervical Cancer Prevention with HPV Vaccines

Authors

  • Chaivanee Kaosayapandhu

Keywords:

Cervical cancer, Human Papillomavirus (HPV), Pap smear, HPV Vaccine, Bivalent vaccine, Quadri- valent vaccine

Abstract

Cervical cancer is the most common malignancy in Thai women with 70% of all cases caused by Human Papillomavirus (HPV) 16, 18 and transmitted by sexual intercourse. Cervical cancer can be prevented by screening tests and HPV vaccines. In Thailand HPV vaccines currently are available in 2 types which are Bivalent, which has HPV 16,18 antigen and AS04 immunizer resulting in high immunization, and Quadrivalent, which has HPV 16,18 antigen and HPV 6,11 antigen which are not the cause of cervical cancer but of genital warts. The result of the study shows the differences of both types of vaccines in immunization mechanism, efficacy, cross-link prevention and indications. Both vaccines are certified for their safety. No severe side effects are found. Mild frequent side effects such as swelling, aching, redness will resolve spontaneously. HPV vaccines are most useful in female adolescents. However, women over 26 years of age or those who have sexual intercourse still benefit from vaccination especially when combined with annual Pap smear screening.

 

Downloads

Published

06-04-2017

How to Cite

Kaosayapandhu, C. (2017). Cervical Cancer Prevention with HPV Vaccines. Siriraj Medical Journal, 65(5), 149–152. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/82342

Issue

Vol. 65 No. 5 (2013): September-October

Section

Review Article

License

Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:

  • Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.